C91.A - Mature B-cell leukemia Burkitt-type
- Applicable to Mature B-cell leukemia Burkitt-type
- The 2025 edition of ICD10-CM C91.A became effective on October 1, 2024.
- This is the American ICD10-CM version of C91.A - other international versions of ICD10 C91.A may differ.
- C91.A is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- C91.A Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- C91.A - Mature B-cell leukemia Burkitt-type
- C91.A - Mature B-cell leukemia Burkitt-type
- C91.A0 - Mature B-cell leukemia Burkitt-type not having achieved remission
- C91.A1 - Mature B-cell leukemia Burkitt-type, in remission
- C91.A2 - Mature B-cell leukemia Burkitt-type, in relapse
Type 1 Excludes
- Burkitt lymphoma (C83.7-)
The following codes above C91.A contain annotation back-references that may be applicable to C91.A:
Chapter: C00-D49 Neoplasms
Section: C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissue
Category: C91 Lymphoid leukemia
Non-Billable/Non-Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com